News Sartorius Stedim Biotech

Equities

DIM

FR0013154002

Market Closed - Euronext Paris Other stock markets 11:38:39 2024-04-19 am EDT			After market 03:59:31 pm
200.6 ^EUR	-4.29%		201.6	+0.52%

Apr. 18	Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...
Apr. 18	Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Sartorius and subsidiary Stedim under pressure after weak figures	Apr. 18	DP
U.S. Futures, European Stocks Rise	Apr. 18	DJ
Sartorius Stedim: Quarterly EPS more than halved	Apr. 18	CF
Sartorius Stedim Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Sartorius Stedim Biotech Records Lower Q1 Attributable Net Profit, Sales Revenue	Apr. 18	MT
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024	Apr. 18	EQ
Ex-dividend day for final dividend	Apr. 01	FA
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.	Mar. 26	EQ
Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call	Mar. 26
SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating	Mar. 12	ZD
Berenberg: Sartorius Stedim Investors Await 'Several Strong Quarters' for Confidence Boost	Feb. 16	MT
Sartorius Stedim Biotech SA: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them	Feb. 16	EQ
Sartorius Stedim Biotech releases Universal Registration Document 2023	Feb. 16	EQ
Sartorius Stedim Biotech: Information on Document Availability	Feb. 16	EQ
Sartorius gains despite halving dividend	Feb. 09	DP
Sartorius Stedim Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
Sartorius Stedim: dividend set for 2023	Feb. 08	CF
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting	Feb. 07	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SARTORIUS STEDIM BIOTECH : FY23: Updated mid-term outlook offers much-valued ‘certainty’

January 30, 2024 at 11:54 am EST